{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Edimer Pharmaceuticals", "item": "https://www.patentleaderboard.com/company/edimer-pharmaceuticals"}, {"@type": "ListItem", "position": 3, "name": "Pascal Schneider", "item": "https://www.patentleaderboard.com/inventor/fl:pa_ln:schneider-22"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
PS

Pascal Schneider — 18 Patents

EPEdimer Pharmaceuticals: 5 patents #1 of 7Top 15%
BMBiogen Ma: 5 patents #150 of 715Top 25%
AAApoxis S. A.: 3 patents #2 of 16Top 15%
ULUniversite De Lausanne: 3 patents #3 of 56Top 6%
UAUniversite Grenoble Alpes: 1 patents #96 of 431Top 25%
Épalinges, CH: #4 of 139 inventorsTop 3%
Overall (All Time): #245,716 of 4,157,543Top 6%
18 Patents All Time
Pascal Schneider has been granted 18 US patents while listed as an inventor at Edimer Pharmaceuticals. The first was granted in 2005 and the most recent in January 2020. Pascal Schneider ranks #245,716 of 4,157,543 US inventors in our database (top 5.9%). Patent records list Pascal Schneider in Épalinges, CH.

Patents per Year

Patents granted per year, 2005 to 2020Bar chart with a peak of 3 patents in 2014.peak 32005: 1 patents20052006: 1 patents2007: 1 patents20072008: 1 patents2010: 1 patents20102013: 2 patents2014: 3 patents20142015: 1 patents2017: 2 patents20172018: 1 patents2019: 3 patents20192020: 1 patents2020

Issued Patents All Time

Showing 1–18 of 18 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
10526412 Anti APRIL (a proliferation-inducing ligand) antibodies and their uses for the prognosis and/or diagnosis of cancer Bertrand Huard 2020-01-07
10494416 Methods of modulating immune responses using BCMA polypeptide Jeffrey Browning, Christine Ambrose, Fabienne MacKay, Jurg Tschopp, Jeffrey Thompson 2019-12-03 $600,375,000
10426819 Treatment of X-linked hypohidrotic ectodermal dysplasia with a fusion EDA1 protein Christine Kowalczyk-Quintas 2019-10-01
10300013 Intra-amniotic administration of EDI200 for the treatment of ectodermal dysplasias Kenneth Huttner, Neil Kirby, Holm Schneider 2019-05-28
9925239 Treatment of X-linked hypohidrotic ectodermal dysplasia with a fusion EDA1 protein Christine Kowalczyk-Quintas 2018-03-27
9695245 Anti-ectodysplasin antibodies Neil Kirby, Christine Kowalczyk-Quintas, Anh Thu Dang 2017-07-04
9650430 Methods of treating autoimmune diseases using a B-cell maturation antigen (BCMA) Jeffrey Browning, Christine Ambrose, Fabienne MacKay, Jurg Tschopp, Jeffrey Thompson 2017-05-16 $369,423,000
9175085 Treatment of X-linked hypohidrotic ectodermal dysplasia with ectodysplasin A agonist Christine Kowalczyk 2015-11-03
8895003 Pharmaceutical composition comprising EDA-1 Fusion Protein Olivier Gaide, Jurg Tschopp 2014-11-25
8828669 Methods of screening for a compound that inhibits the interaction between BAFF and BCMA Jeffrey Browning, Christine Ambrose, Fabienne MacKay, Jurg Tschopp, Jeffrey Thompson 2014-09-09
8741297 Preparation of isolated agonist anti-EDAR monoclonal antibodies Nathalie Dunkel, Stephane Demotz 2014-06-03
8501177 Treatment of ectodermal dysplasia with EDA1 fusion proteins Olivier Gaide, Jurg Tschopp 2013-08-06
8496937 Preparation of isolated agonist anti-EDAR monoclonal antibodies Nathalie Dunkel, Stephane Demotz 2013-07-30
7736657 Fusion constructs containing active sections on TNF ligands Olivier Gaide, Jurg Tschopp 2010-06-15
7385032 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins Jurg Tschopp, Nils Holler 2008-06-10
7276241 Methods of treating a tumor that expresses APRIL by administering BCMA Jeffrey Thompson, Teresa G. Cachero, Christine Ambrose, Paul Rennert 2007-10-02
7083785 Methods of treatment by administering an anti-BCMA antibody Jeffrey Browning, Christine Ambrose, Fabienne MacKay, Jurg Tschopp, Jeffrey Thompson 2006-08-01
6869605 BAFF, inhibitors thereof and their use in the modulation of B-cell response Jeffrey Browning, Christine Ambrose, Fabienne MacKay, Jurg Tschopp 2005-03-22